Conmed CNMD
NYSE CNMD
$46.99 +0.40 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Conmed (CNMD) Non-Current Debt (2010 - 2026)

Conmed's (CNMD) quarterly Non-Current Debt came in at $657.0 million in Q2 2026, down 25.43% on a YoY basis from $881.1 million in Q2 2025, and down 23.61% quarter-over-quarter from $860.2 million in Q1 2026.

Analysis

Conmed (CNMD) Non-Current Debt (2010 - 2026) Analysis & Trends

Conmed (CNMD) has reported Non-Current Debt for 17 consecutive years, with $657.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Debt fell 25.43% year-over-year to $657.0 million; the trailing twelve-month figure through Jun 2026 stood at $657.0 million (down 25.43% YoY), and the FY2025 full-year result was $834.2 million, down 7.83% from the prior year.
  • Non-Current Debt slipped to $657.0 million in Q2 2026 per CNMD's latest filing, from $860.2 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.0 billion in Q3 2022 and bottomed at $657.0 million in Q2 2026.
  • Historically, Non-Current Debt has averaged $909.3 million across 5 years, with a median of $941.1 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Non-Current Debt soared 47.36% in 2022, then decreased 25.43% in 2026.
  • Over 5 years, Non-Current Debt stood at $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025, then decreased by 21.24% to $657.0 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $657.0 million, $860.2 million, and $834.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 25.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 1.65 Bn
10 Conmed 1.42 Bn 1.38 Bn 197.46 Mn 657.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 657.05 Mn
Mar 31, 2026 860.16 Mn
Dec 31, 2025 834.23 Mn
Sep 30, 2025 853.01 Mn
Jun 30, 2025 881.11 Mn
Mar 31, 2025 891.44 Mn
Dec 31, 2024 905.07 Mn
Sep 30, 2024 940.09 Mn
Jun 30, 2024 965.17 Mn
Mar 31, 2024 990.11 Mn
Dec 31, 2023 973.14 Mn
Sep 30, 2023 942.17 Mn
Jun 30, 2023 971.48 Mn
Mar 31, 2023 995.28 Mn
Dec 31, 2022 985.08 Mn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 982.43 Mn
Mar 31, 2022 703.54 Mn
Dec 31, 2021 672.41 Mn
Sep 30, 2021 703.34 Mn